US74435K2042 - ADR

Overall **PUK** gets a fundamental rating of **3** out of 10. We evaluated **PUK** against 141 industry peers in the **Insurance** industry. Both the profitability and financial health of **PUK** have multiple concerns. **PUK** is valued expensive and it does not seem to be growing.

In the past year **PUK** was profitable.

In the past year **PUK** had a positive cash flow from operations.

In multiple years **PUK** reported negative net income over the last 5 years.

In multiple years **PUK** reported negative operating cash flow during the last 5 years.

The **Return On Equity** of **PUK** (**5.42%**) is worse than **66.43%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.5% | ||

ROE | 5.42% | ||

ROIC | 0.88% |

ROA(3y)-0.23%

ROA(5y)-0.02%

ROE(3y)-2.81%

ROE(5y)1.15%

ROIC(3y)N/A

ROIC(5y)N/A

Looking at the **Operating Margin**, with a value of **17.70%**, **PUK** is in the better half of the industry, outperforming **74.29%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 17.7% | ||

PM (TTM) | 8.44% | ||

GM | N/A |

OM growth 3Y43.57%

OM growth 5Y16.17%

PM growth 3Y39.78%

PM growth 5Y7.31%

GM growth 3YN/A

GM growth 5YN/A

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), **PUK** is destroying value.

Compared to 1 year ago, **PUK** has an improved debt to assets ratio.

The **Debt to FCF ratio** of **PUK** (**2.90**) is worse than **60.00%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.3 | ||

Debt/FCF | 2.9 | ||

Altman-Z | N/A |

ROIC/WACC0.11

WACC8%

A Current Ratio of **0.57** indicates that **PUK** may have some problems paying its short term obligations.

The **Current ratio** of **PUK** (**0.57**) is better than **75.00%** of its industry peers.

A Quick Ratio of **0.57** indicates that **PUK** may have some problems paying its short term obligations.

Looking at the **Quick ratio**, with a value of **0.57**, **PUK** is in the better half of the industry, outperforming **75.00%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.57 | ||

Quick Ratio | 0.57 |

The earnings per share for **PUK** have decreased strongly by **-39.61%** in the last year.

The earnings per share for **PUK** have been decreasing by **-16.87%** on average. This is quite bad

The **Revenue** has been growing slightly by **3.04%** in the past year.

The Revenue for **PUK** have been decreasing by **-21.54%** on average. This is quite bad

EPS 1Y (TTM)-39.61%

EPS 3Y-8.56%

EPS 5Y-16.87%

EPS Q2Q%-87.3%

Revenue 1Y (TTM)3.04%

Revenue growth 3Y-33.5%

Revenue growth 5Y-21.54%

Sales Q2Q%-4.93%

EPS Next Y6.16%

EPS Next 2Y7.33%

EPS Next 3Y9.43%

EPS Next 5Y11.65%

Revenue Next Year-3.43%

Revenue Next 2Y4.6%

Revenue Next 3Y-2.73%

Revenue Next 5Y-11.66%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Based on the **Price/Earnings** ratio, **PUK** is valued a bit more expensive than 68.57% of the companies in the same industry.

Compared to an average S&P500 **Price/Earnings** ratio of **30.52**, **PUK** is valued at the same level.

A **Price/Forward Earnings** ratio of **7.77** indicates a rather cheap valuation of **PUK**.

Based on the **Price/Forward Earnings** ratio, **PUK** is valued a bit cheaper than the industry average as 67.86% of the companies are valued more expensively.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **21.99**, **PUK** is valued rather cheaply.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 25.75 | ||

Fwd PE | 7.77 |

Based on the **Price/Free Cash Flow** ratio, **PUK** is valued a bit more expensive than 62.14% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 13.42 | ||

EV/EBITDA | N/A |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

PEG (NY)4.18

PEG (5Y)N/A

EPS Next 2Y7.33%

EPS Next 3Y9.43%

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.61% |

The dividend of **PUK** decreases each year by **-21.30%**.

Dividend Growth(5Y)-21.3%

Div Incr Years3

Div Non Decr Years3

DP64.08%

EPS Next 2Y7.33%

EPS Next 3Y9.43%

**PRUDENTIAL PLC-ADR**

NYSE:PUK (9/13/2024, 8:04:00 PM)

After market: 17.2 +0.72 (+4.37%)**16.48**

**+0.11 (+0.67%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupInsurance

GICS IndustryInsurance

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap22.61B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.61% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 25.75 | ||

Fwd PE | 7.77 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)4.18

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.5% | ||

ROE | 5.42% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 17.7% | ||

PM (TTM) | 8.44% | ||

GM | N/A | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.06

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.3 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.57 | ||

Quick Ratio | 0.57 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-39.61%

EPS 3Y-8.56%

EPS 5Y

EPS Q2Q%

EPS Next Y6.16%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)3.04%

Revenue growth 3Y-33.5%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y